| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |